Tueni EA - Search Results

1

Gemcitabine plus carboplatin combination therapy as second-line treatment in patients with relapsed breast cancer.

Nasr FL, Chahine GY, Kattan JG, Farhat FS, Mokaddem WT, Tueni EA, Dagher JE, Ghosn MG. Nasr FL, et al. Among authors: tueni ea. Clin Breast Cancer. 2004 Jun;5(2):117-22; discussion 123-4. doi: 10.3816/cbc.2004.n.015. Clin Breast Cancer. 2004. PMID: 15245614 Clinical Trial.

2

Phase I study of a carboplatin-etoposide combination in advanced thoracic cancer.

Tueni E, Sculier JP, Klastersky J. Tueni E, et al. Eur J Cancer Clin Oncol. 1988 Jun;24(6):963-7. doi: 10.1016/0277-5379(88)90143-5. Eur J Cancer Clin Oncol. 1988. PMID: 3044803

3

Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer.

Paridaens R, Focan C, Michel J, Piccart M, Salamon E, Beauduin M, Closon MT, Tueni E, Vindevoghel A, Majois F, et al. Paridaens R, et al. Cancer Chemother Pharmacol. 1990;26 Suppl:S63-5. doi: 10.1007/BF00685423. Cancer Chemother Pharmacol. 1990. PMID: 2112055

4

Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.

Punt CJ, Voest EE, Tueni E, Van Oosterom AT, Backx A, De Mulder PH, Hecquet B, Lucas C, Gerard B, Bleiberg H. Punt CJ, et al. Br J Cancer. 1997;76(10):1376-81. doi: 10.1038/bjc.1997.563. Br J Cancer. 1997. PMID: 9374386 Free PMC article. Clinical Trial.

5

Who should be screened for hereditary breast cancer and what should be done with the information?

Saade M, Salamoun W, Tueni E, Shami PJ. Saade M, et al. J Med Liban. 1999 Sep-Oct;47(5):281-3. J Med Liban. 1999. PMID: 10887526 No abstract available.

6

Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive days.

Dodion P, de Valeriola D, Crespeigne N, Peeters B, Wery F, van Berchem C, Piccart M, Tueni E, Joggi J, Kenis Y. Dodion P, et al. Eur J Cancer Clin Oncol. 1988 Jun;24(6):1019-26. doi: 10.1016/0277-5379(88)90152-6. Eur J Cancer Clin Oncol. 1988. PMID: 2970391

7

Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Steward WP, Verweij J, Somers R, Spooner D, Kerbrat P, Clavel M, Crowther D, Rouesse J, Tursz T, Tueni E, et al. Steward WP, et al. J Clin Oncol. 1993 Jan;11(1):15-21. doi: 10.1200/JCO.1993.11.1.15. J Clin Oncol. 1993. PMID: 8418226

8

Subrenal capsule assay for fresh human tumors in immunocompetent mice; an inappropriate technique for non-small cell lung cancer.

Tueni EA, Dumont P, Jacobovitz D, Atassi G, Rocmans P, Lejeune F, de Franquen P, Semal P, Klastersky J. Tueni EA, et al. Eur J Cancer Clin Oncol. 1987 Aug;23(8):1163-7. doi: 10.1016/0277-5379(87)90150-7. Eur J Cancer Clin Oncol. 1987. PMID: 2820747

9

Validation of clinical predictive value of in vitro colorimetric chemosensitivity assay in head and neck cancer.

Schroyens W, Tueni E, Dodion P, Bodecker R, Stoessel F, Klastersky J. Schroyens W, et al. Eur J Cancer. 1990;26(7):834-8. doi: 10.1016/0277-5379(90)90165-p. Eur J Cancer. 1990. PMID: 2145907

10

[Epidural metastases at the level of the spine: a medical emergency].

Tueni EA, Klastersky J, Retif J. Tueni EA, et al. Rev Med Brux. 1987 Feb;8(2):85-91. Rev Med Brux. 1987. PMID: 3563186 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters